BioStock: CLS sees opportunity to increase revenue

In the year-end report for 2023, CLS summarizes an eventful year with increased revenues, primarily driven by the urology segment and the new Mobile Service Provider model. Moreover, the company has identified a way to increase revenues within the neurosurgery segment.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/03/cls-sees-opportunity-to-increase-revenue/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se